Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.648 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.645 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.640 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.627 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.627 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.611 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.611 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.604 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.602 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.602 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.601 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.598 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.597 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.592 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.591 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.591 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.589 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.570 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.553 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.548 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.546 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.545 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.540 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.540 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.535 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.534 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.532 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.527 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.526 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.526 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.525 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.523 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.523 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.522 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.522 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.521 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.516 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.515 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.515 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.514 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.513 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.507 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.507 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.504 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.502 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.502 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.501 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.501 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.501 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.500 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.499 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.499 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.499 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.498 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.498 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.497 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.497 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.497 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.496 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.496 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.496 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.495 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.494 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.493 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.493 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.493 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.492 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.492 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.491 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.491 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.490 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.490 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.490 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.489 | |
3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.489 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.489 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.489 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.488 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.487 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.487 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.487 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.487 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.486 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.485 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.484 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.484 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.483 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.483 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.483 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.483 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.482 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.482 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.481 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.481 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.481 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.480 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.480 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.480 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.480 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.480 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.480 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.479 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.479 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.478 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.478 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.478 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.477 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.477 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.476 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.476 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.476 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.475 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.475 | |
3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.474 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.474 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.474 | |
1xdd | AAY | Integrin alpha-L | / | 0.473 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.473 | |
2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.473 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.473 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.472 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.472 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.471 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.471 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.471 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.470 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.470 | |
4yt5 | H4M | H(2)-forming methylenetetrahydromethanopterin dehydrogenase-related protein MJ1338 | / | 0.470 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.469 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.469 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.469 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.468 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.468 | |
1ie4 | T44 | Transthyretin | / | 0.467 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.467 | |
3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.467 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.467 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.466 | |
2wec | PP5 | Penicillopepsin-1 | 3.4.23.20 | 0.466 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.466 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.466 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.465 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.465 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.465 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.465 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.465 | |
1c6y | MK1 | Protease | / | 0.464 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.464 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.464 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.464 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.464 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.463 | |
4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.463 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.463 | |
4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.463 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.463 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.463 | |
4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.463 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.462 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.462 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.462 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.461 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.461 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.461 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.461 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.461 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.461 | |
1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.460 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.459 | |
3icr | COA | Coenzyme A disulfide reductase | / | 0.459 | |
3uix | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.459 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.458 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.458 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.458 | |
4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.458 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.458 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.457 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.457 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
3slk | NDP | Polyketide synthase extender module 2 | / | 0.457 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.457 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.456 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.456 | |
3nbv | ANP | Ketohexokinase | / | 0.456 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.456 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.455 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.455 | |
3upj | U03 | Gag-Pol polyprotein | / | 0.455 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.455 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.455 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.455 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.455 | |
4mcb | 21W | tRNA (guanine-N(1)-)-methyltransferase | 2.1.1.228 | 0.455 | |
1i8t | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.454 | |
2uy0 | HV1 | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.454 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3nbw | TR4 | Ketohexokinase | / | 0.454 | |
3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.454 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4pd6 | URI | Nucleoside permease | / | 0.454 | |
1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.453 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.453 | |
3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.453 | |
3mg3 | ECH | Orange carotenoid-binding protein | / | 0.453 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.453 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.453 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.453 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.452 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.452 | |
3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.452 | |
3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.452 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.452 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.452 | |
4ejn | 0R4 | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.452 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
1jld | 0PP | Gag-Pol polyprotein | / | 0.451 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
2jd0 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.451 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
2yyi | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.451 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.451 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.451 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
4g3e | 0WC | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.451 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.451 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.450 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.450 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.450 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.450 | |
3sp6 | IL2 | Peroxisome proliferator-activated receptor alpha | / | 0.450 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.450 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.450 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.450 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.450 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.450 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.450 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.450 | |
1ebk | 0Q4 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
1wbk | 568 | Pol protein | / | 0.449 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
3bgr | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
3ogq | AB1 | Pol polyprotein | / | 0.449 | |
3t8o | ATP | Rhodopsin kinase | / | 0.449 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.449 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.449 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.449 | |
5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.449 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1hii | C20 | Gag-Pol polyprotein | / | 0.448 | |
1xq6 | NAP | Uncharacterized protein At5g02240 | / | 0.448 | |
1zmc | NAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.448 | |
2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.448 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
3dcr | KVS | Protease | / | 0.448 | |
3kdd | JZQ | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
4djp | M73 | Pol polyprotein | / | 0.448 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.448 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.448 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.448 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
3qak | UKA | Adenosine receptor A2a | / | 0.448 | |
2k62 | ITL | Fatty acid-binding protein, liver | / | 0.447 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
2xye | CXG | Gag-Pol polyprotein | / | 0.447 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.447 | |
3lin | E13 | Protease | / | 0.447 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.447 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
4ewh | T77 | Activated CDC42 kinase 1 | / | 0.447 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.447 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.447 | |
4y8w | STR | Steroid 21-hydroxylase | / | 0.447 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.447 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.446 | |
2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2yki | YKI | Heat shock protein HSP 90-alpha | / | 0.446 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
3opd | HIE | Heat shock protein 83 | / | 0.446 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.446 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.445 | |
2q4b | NAP | Uncharacterized protein At5g02240 | / | 0.445 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.445 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.445 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.445 | |
3qa2 | XNA | Ketohexokinase | / | 0.445 | |
3s43 | 478 | Protease | / | 0.445 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.445 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.445 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
1bdr | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.444 | |
1gqt | ACP | Ribokinase | / | 0.444 | |
1hos | PHP | Gag-Pol polyprotein | / | 0.444 | |
1mes | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
1q0q | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.444 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
2fdd | 385 | Pol protein | / | 0.444 | |
2igo | FAD | Pyranose 2-oxidase | / | 0.444 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.444 | |
2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.444 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.444 | |
3sac | AF8 | Protease | / | 0.444 | |
3tvu | B37 | Acetyl-CoA carboxylase | / | 0.444 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.444 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
4j55 | 031 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.444 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1d4i | BEG | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.443 | |
2ivn | ANP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.443 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.443 | |
2yjx | YJX | Heat shock protein HSP 90-alpha | / | 0.443 | |
2zb3 | NDP | Prostaglandin reductase 2 | 1.3.1.48 | 0.443 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.443 | |
3qai | XNN | Ketohexokinase | / | 0.443 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.443 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.443 | |
4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.443 | |
1eby | BEB | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
1hvr | XK2 | Gag-Pol polyprotein | / | 0.442 | |
1osv | CHC | Bile acid receptor | / | 0.442 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
2b7z | MK1 | Gag-Pol polyprotein | / | 0.442 | |
3cwk | REA | Cellular retinoic acid-binding protein 2 | / | 0.442 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.442 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.442 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
3q44 | D50 | M1 family aminopeptidase | 3.4.11 | 0.442 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.442 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
1bvg | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
1c1d | NAI | Phenylalanine dehydrogenase | / | 0.441 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1sh9 | RIT | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2bqv | A1A | Protease | / | 0.441 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.441 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.441 | |
2ykj | YKJ | Heat shock protein HSP 90-alpha | / | 0.441 | |
2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.441 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.441 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.441 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.441 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.441 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.441 | |
4z24 | FAD | Putative GMC-type oxidoreductase R135 | 1 | 0.441 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.441 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.441 | |
1dw6 | 0Q4 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1ec0 | BED | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.440 | |
2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.440 | |
2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3q92 | XNB | Ketohexokinase | / | 0.440 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.440 | |
4n6b | COA | Uncharacterized protein | / | 0.440 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.440 | |
5iub | CLR | Adenosine receptor A2a | / | 0.440 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.440 |